AlphaQuest’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,250
Closed -$49.6K 1892
2025
Q4
$49.6K Hold
20,250
﹤0.01% 1941
2025
Q3
$136K Hold
20,250
0.01% 1589
2025
Q2
$119K Buy
20,250
+9,804
+94% +$63.9K 0.01% 1371
2025
Q1
$87.6K Sell
10,446
-1,809
-15% -$16.3K 0.01% 1358
2024
Q4
$91.2K Buy
+12,255
New +$82K 0.01% 1124
2024
Q2
Sell
-1,198
Closed -$15.6K 1895
2024
Q1
$15.6K Sell
1,198
-4,172
-78% -$55.6K ﹤0.01% 1050
2023
Q4
$68.5K Buy
+5,370
New +$54.3K 0.01% 835

Other funds holding TMCI

AlphaQuest's TMCI Position: Q1 2026 in Review

AlphaQuest sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 20,250 shares — an estimated $49.6K sold.

AlphaQuest first reported a position in TMCI in Q4 2023 and held it in 7 quarters. The position peaked at $136K in Q3 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • AlphaQuest reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 20,250 Treace Medical Concepts shares in Q1 2026, an estimated $49.6K.
  • AlphaQuest first reported a position in Treace Medical Concepts in Q4 2023 and held it in 7 quarters.
  • AlphaQuest's Treace Medical Concepts position peaked at $136K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.